Comparison of FDG-PET and levels of Tau protein in patients with Alzheimer's disease.

被引：0
|
作者：
Newberg, A [1 ]
Alavi, A [1 ]
Clark, C [1 ]
Mozley, PD [1 ]
Arai, H [1 ]
机构：
[1] HOSP UNIV PENN,PHILADELPHIA,PA 19104
来源：
JOURNAL OF NUCLEAR MEDICINE | 1997年 / 38卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：481 / 481
页数：2
相关论文
共 50 条
  • [31] Neural Correlates of Stroop Performance in Alzheimer's Disease: A FDG-PET Study
    Yun, Je-Yeon
    Lee, Dong Young
    Seo, Eun Hyun
    Choo, Il Han
    Park, Shin Young
    Kim, Shin Gyeom
    Woo, Jong In
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 190 - 201
  • [32] Therapy control of cholinesterase inhibitors in Alzheimer's disease using FDG-PET
    Kratzsch, T
    Kramer, J
    Peters, J
    Frölich, L
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S369 - S369
  • [33] Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study
    Mosconi, L
    Sorbi, S
    Nacmias, B
    De Cristofaro, MTR
    Fayyaz, M
    Bracco, L
    Herholz, K
    Pupi, A
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2004, 130 (02) : 141 - 151
  • [34] FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
    Foster, Norman L.
    Heidebrink, Judith L.
    Clark, Christopher M.
    Jagust, William J.
    Arnold, Steven E.
    Barbas, Nancy R.
    DeCarli, Charles S.
    Turner, R. Scott
    Koeppe, Robert A.
    Higdon, Roger
    Minoshima, Satoshi
    BRAIN, 2007, 130 : 2616 - 2635
  • [35] FDG-PET following treatment as valid predictor for disease free survival in Hodgkin's disease.
    de Wit, M
    Bohuslavizki, KH
    Bleckmann, C
    Clausen, M
    Hossfeld, DK
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 210P - 210P
  • [36] Diagnostic utility of FDG-PET in detecting Alzheimer's disease in patients with persistent MCI of uncertain origin
    Boccardi, M.
    Festari, C.
    Arbizu, J.
    Orini, S.
    Gandolfo, F.
    Altomare, D.
    Rivolta, J.
    Frisoni, G.
    Nobili, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 447 - 448
  • [37] Evaluation of the relationship between FDG-PET hypometabolism and retinal layer thickness in patients with Alzheimer's disease
    Duman Sastim, Demet
    Elboga, Gulcin
    Elboga, Umut
    Gungor, Kivanc
    ACTA NEUROLOGICA BELGICA, 2024, 124 (03) : 987 - 993
  • [38] Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
    Oliver Goldhardt
    Inanna Warnhoff
    Igor Yakushev
    Ilijana Begcevic
    Hans Förstl
    Viktor Magdolen
    Antoninus Soosaipillai
    Eleftherios Diamandis
    Panagiotis Alexopoulos
    Timo Grimmer
    Translational Neurodegeneration, 8
  • [39] Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET
    Goldhardt, Oliver
    Warnhoff, Inanna
    Yakushev, Igor
    Begcevic, Ilijana
    Foerstl, Hans
    Magdolen, Viktor
    Soosaipillai, Antoninus
    Diamandis, Eleftherios
    Alexopoulos, Panagiotis
    Grimmer, Timo
    TRANSLATIONAL NEURODEGENERATION, 2019, 8 (01)
  • [40] APP and tau phosphorylation in Alzheimer's disease.
    Davies, P
    DeBernardis, J
    Espinoza, M
    Stahl, M
    Vianna, C
    BRAIN PATHOLOGY, 2000, 10 (04) : 493 - 493
12345